Children´s hospital in Buenos Aires received medical cannabis for treatment
The products will mainly be used for palliative purposes.

The Garrahan National Children's Hospital in Buenos Aires has just provided the first shipment of medical cannabis in Buenos Aires, the capital of Argentina. The Argentine health authorities now allow access to cannabis derivatives for medical, therapeutic and palliative purposes. The first shipment of medical cannabis for pediatric epilepsy patients at Buenos Aires National Children's Hospital, Garrahan, has finally been delivered. The delivery was a long-awaited result of Law 27,350. The law was passed in 2017 but was not regulated until November last year. The young patients of the hospital now receive treatment with purified and highly concentrated cannabis oil in pharmaceutical quality. It is intended for patients with drug-resistant epilepsy, i. that is, if a person does not remain seizure-free after two attempts at anti-seizure medication. The medical marijuana is also used to treat patients with seizures related to Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS), and epilepsy related to tuberous sclerosis. LGS and DS are often resistant to treatment and lead to cognitive and behavioral changes. In over 80 percent of cases, cannabis has been shown to improve the quality of life of patients. The drug has also reportedly reduced the number of seizures by 60 percent. Bottles of oral cannabis solution were delivered to the Garrahan National Children's Hospital in Buenos Aires, Argentina. Health Access Secretary Sandra Tirado said this is the first time a derivative of nationally produced cannabis "is available to patients. The first delivery of the solution will treat 14 children. Medical Cannabis Program Coordinator Marcelo Morante stated: "The quality of a standardized product for a disease that really affects the quality of life of our families, accompanied by a doctor or reference hospital for refractory epilepsy, is the path that takes us to improve this debilitating disease will result. " Medical cannabis will bring comfort not only to patients suffering from frequent, sometimes daily, and severe seizures, but also to their families. According to Garrahan Hospital's chief neurologist, Roberto Caravallo, the hospital's new treatment "will lead to a better quality of life for the child and their family." Previously, cannabis oil was only available to participants in research protocols in refractory epilepsy.





